4Filing Date: Mar 30, 2026
Gilead (GILD) 4: O'Day Daniel Patrick sold 10,000 shares of Common Stock at… (Mar 30, 2026)
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0001638643-26-000018
Total Value$1.37M
Trades1
Insiders1
Transaction Details
O'Day Daniel Patrick
Chairman & CEO, Director·Direct
Sell · Dispose
Common Stock
Shares-10.00K
Price$136.82
Total Value$1.37M
Shares Owned After642.57K
Transaction DateMar 27, 2026
10b5-1
Footnotes ▸
The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025. | Sale prices for the transactions reported range from $136.51 to $137.22. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
Post-Transaction Holdings
O'Day Daniel Patrick · Chairman & CEO, Director
| Security | Shares | Change |
|---|---|---|
| Common Stock | 642.57K | -10.00K (-1.53%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-03-27
10b5-1 Pre-arranged Plan: Yes
--- Issuer ---
Name: GILEAD SCIENCES, INC. (GILD)
CIK: 0000882095
--- Reporting Owner ---
Name: O'Day Daniel Patrick
CIK: 0001638643
Role: Director, Officer (Chairman & CEO)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-03-27 | Code: S (Open market sale)
Shares: -10,000 | Price: $136.82
Total Value: $1,368,162.00
Shares Owned After: 642,567 | Ownership: D (Direct)
Footnotes:
[F1] The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025.
[F2] Sale prices for the transactions reported range from $136.51 to $137.22. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
--- Footnotes (Complete Index) ---
F1: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025.
F2: Sale prices for the transactions reported range from $136.51 to $137.22. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
--- Signature ---
/s/ /s/ Amy Kim by Power of Attorney for Daniel O'Day (2026-03-30)